chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chronic headaches; migraines; Fatigue; shortness of breath; Disorientation; dizziness; Neurological symptoms (numbing in various parts of body, including face and lips; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 34 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 16Apr2021 09:15 (Lot number: EW0164) at the age of 34 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset 2021, outcome "not recovered", described as "Chronic headaches"; MIGRAINE (non-serious) with onset 2021, outcome "not recovered", described as "migraines"; FATIGUE (non-serious) with onset 2021, outcome "not recovered", described as "Fatigue"; DYSPNOEA (non-serious) with onset 2021, outcome "not recovered", described as "shortness of breath"; DISORIENTATION (non-serious) with onset 2021, outcome "not recovered", described as "Disorientation"; DIZZINESS (non-serious) with onset 2021, outcome "not recovered", described as "dizziness"; HYPOAESTHESIA (non-serious) with onset 2021, outcome "not recovered", described as "Neurological symptoms (numbing in various parts of body, including face and lips". It was unknown if therapeutic measures were taken as a result of headache, migraine, fatigue, dyspnoea, disorientation, dizziness, hypoaesthesia.  Additional information: Chronic headaches & migraines. Fatigue and shortness of breathe. Disorientation & dizziness. Neurological symptoms (numbing in various parts of body, including face and lips). All of these symptoms occurring to various degrees for the last 5+ months. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. Other medications in two weeks was reported as not applicable.  No follow-up attempts are possible. No further information is expected.
Redness and induration began within 5-10 minutes after immunizations below the MMR site on right upper arm. Dollar-sized red area, dime sized induration. Benadryl 50mg administered to left thigh and client observed for 30 minutes. Redness began to fade. No itching, hives, scratchy throat or breathing problems observed. Referred to private MD
pt had a positive COVID test on 1/29/22 in rehab center; pt transported to medical center's ED with hypoxic respiratory failure related to COVID PNA; pt was intubated and on a ventilator; Emergency helicopter ride to a different medical center; decompensated and went into cardiac arrest after landing; ROSC achieved; pt was pulseless in ED; coded off and on for 1.5 hrs and never achieved ROSC
A couple of weeks later (March 20, 2021) I have a hives attack and then the next day I went to my allergist and the nurse practitioner mentioned that people have checked in with her as well after their 2nd dose and have the same issue. She prescribed me with Hydroxyzine HCI (25mg), after taking the medication the hives went away after 24 hours.
It was mid November One day I was at work at got extremely dizzy and then the headaches started. This morning I had a little Diarrhea but I don't know if that's related. a few days ago I notice my mouth dry and I taste a lot of saltiness. I had a bad headache on 12/10/2021 and yesterday 12/12/2021 and times I went to the ER, I was told I couldn't do anything for me.
Confusion, SkinRash, angio edema, lethargic Narrative:  Lethargic, confusion, angio edema, rash left forearm, right inner thigh, right forearm; will call PCP for treatment. Denies SOA or interference of airway with angio edema.  Other Relevant History:
MA discussed egg allergy w/Dr and was given ok to go ahead and give immunization as pt has been able to eat egg baked in things and also had no previous reaction to two prior flu shots. Immunizations were given by MA. About 5 minutes later parent notice rash developing on legs R greater than L. Hive like rash noted around right thigh flu shot injection site. Dr was alerted and evaluated patient. RN gave oral liquid BENADRYL to patient without difficulty. Parents were instructed on as needed BENADRYL dosing. Patient left with parents w/o further concerns.
Normal pain after injection, but after a week my upper arm swelled up, skin was hot, itchy and painful.  It lasted a week and dissipated.
I currently have swelling in my hands, pain in my vaccinated arm, bone pain, a bump in my hand like thrombi, burning sensation in my stomach, taste of blood in my throat, leg and joint pain. After I was vaccinated.
pt passed out 5 minutes after the shot was given. Then the pt started to shake a little for about 10 -15 seconds. When pt came back to she vomitted. Pt felt better about 5 minutes after event.
pt recvd vax on 10NOV95;1-3 hrs later devel sxs of h/a, muscle aches which lasted approx 30hrs;
12 hours after receiving my booster I got up to go to the bathroom at 2 a.m. and fainted. My husband caught me. I collapsed. After coming to I immediately had to take a bowel movement and broke into an intense sweat. Followed by chills for 2 hours/. I could not get warm. The next day I had a fever of 102.
Began with rash mid p.m. on 5-17-11 on forehead and back. 5-18-11 in a.m. then began on chest. Appears to be moving down legs this p.m. (5-18-11). No fever. Appetite gd. No diarrhea or vomit. May use OTC Acetaminiophen/Ibuprofen if needed prn, discomfort. Using sunscreen.
This spontaneous report as received from a registered nurse refers to multiple patients of unknown age and gender. On an unknown date, the patients were vaccinated with (Oka/Merck) VARIVAX lot # K009756 and K009758, with expiry date 09-JUL-2016, that was improperly stored. No adverse effects were reported. The outcome of the improper storage of vaccine was not known. This is one of two reports received from the same source. Additional information has been requested.
As per physician's documentation on 01/07/2020: "Got flu vaccine in November and still has 'bruise' around it on left thigh. Hyperpigmented/brown somewhat reticular pattern in an oval, does not blanch, about 5 cm x 4 cm in diameter. Painless. Not itchy or bothersome. Will ask RN to report as adverse reaction, but not dangerous, no treatment needed."
approximately two weeks after my first injection I came down with a terrible cold and then swelling and pain in my right foot. I also started noticing less sensitivity in my hands, cold feet and weakness in my hands. After I received my second shot, the pain in my feet worsened, I had extreme pain in my lower back. My chest congestion continues and my voice is raspy.
Fatigue-treatment frequent naps Rash on toes legs stomach arms back treatment hydrocortisone  Headache treatment Tylenol
They are infected or quarantining from exposure to someone with active infection after the 1st dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE TO SARS-COV-2 (They are infected or quarantining from exposure to someone with active infection after the 1st dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPOSURE TO SARS-COV-2 (They are infected or quarantining from exposure to someone with active infection after the 1st dose). At the time of the report, EXPOSURE TO SARS-COV-2 (They are infected or quarantining from exposure to someone with active infection after the 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Information has been received from a medical assistant concerning a female who on an unspecified date was vaccinated with a dose of Varivax. Subsequently, the patient developed a mild case of chickenpox "two weeks ago" approximately 15-DEC-2006. it was unspecified if medical attention was sought. No outcome information was reported. It was also reported that the patient's sister developed a "full blown" case of chickenpox after Varivax (WAES# 0701USA00227). Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. "Last month", in September 2014 the patient was administered a first dose of PNEUMOVAX 23 (lot#, dose, route not reported). "Yesterday", on 21-OCT-2014 the patient was inadvertently administered a 2nd dose of PNEUMOVAX 23 (lot#, dose, route not reported). No adverse effect was reported. Additional information has been requested.
I had my vaccination on 09/19/2022. On 02/27/2023 I developed symptoms to include congestion low grade fever and cough. The urgent care gave me a cough suppressant and decongestant. I went back to the urgent care 4 days later as I was getting worse and they prescribed an antibiotic.
Patient received Pfizer COVID vaccine on 1/8/21 (lot # EL1284), 1/29/21 (lot # EN5201), and 10/31/21 (lot # EW0185). On 1/25/22, patient admitted to our inpatient facility (med/surg unit) with septic shock, complicated UTI from chronic suprapubic catheter, acute metabolic encephalopathy, and hyperkalemia. Patient transferred on 1/27/22 and back to med/surg unit by end of day. On 1/28/22, patient tested positive for COVID and started having hypoxia. As of today (2/3/22), patient is still admitted in the med/surg unit.
Subsequent to receiving vax, the pt developed a local reaction of redness, swelling and hardness. No specifics were provided. Further information requested.
Patient states she felt numbness in her tongue and numbness and tingling in her left arm. She waited at the pharmacy past 15 mins to ensure to greater reaction. She stated she felt rushed by her parents and her body may have reacted from the urgency. Patient felt fine and comfortable before leaving pharmacy.
fever, chills, malaise, & extreme soreness, redness & swelling in lt arm the next day;an area of redness & swelling the size of a hand was still  evident @ 48hr
Patient received 2 doses 31 days apart; This case was reported by a pharmacist and described the occurrence of drug dose administration interval too short in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The patient received second dose of Shingrix 31 days apart from first dose, which led to shortening of vaccination schedule. No other information was reported.
Body aches, migraines. These symptoms started about 8 hours after the vaccine was recieved and lasted about 16 hours.
This spontaneous report was received from a Nurse refers to a 22 year old female patient. On an unkonwn date, the patient was vaccinated with VARIVAX (Merck) 0.5 ml subcutaneous and was also vaccinated with M-M-R II (dose, route and frequency was not reported). It was reported that on an unknown date, the result of unspecified tests on unspecified dates was that the patient did not have adequate immunity from VARIVAX (Merck) and M-M-R II. On an unkonwn date, the patient was administered with the third dose of VARIVAX (Merck) 0.5 ml subcutaneous. The outcome of the event did not have adequate immunity was unknown. The reporter did not provide the causality between the event and the suspect drugs. This case is linked to the case 1402USA009677 (same reporter link). Additional information has been requested.
Initial unsolicited report received from a nurse (who was reporting for self) on 31 August 2015. This case involves a 63-year-old female patient who was vaccinated with a dose of ADACEL (batch number, dose, dose in series and expiry date were not reported) intramuscularly in left deltoid on 29 August 2015. The patient's pre-existing physician diagnosed allergies, birth defects, medical conditions reported as asthma, numerous allergies with chicken, beta blockers, cephalosporins, penicillin, amoxicillin, opiates, Mucomyst, NEURONTIN, compazine, Coumadin, bisphosphonates, Synthroid, Tylenol, medocatopm, oral contrast dye, coffee, corn, almonds, perfumes, pesticides, smoke. Concomitant medications were not reported. On 29 August 2015, same day following the vaccination, the patient experienced troubled breathing that lasted for the next 24 hours. Thereafter she did not have any other symptoms. Laboratory data and corrective treatment were not reported. On an unknown date (after 24 hours), the patient recovered from the event. List of documents held by sender: none.
Redness and itching to right arm, onset 22 hours after vaccination. Benedryl 50mg PO with good results
Patient was here to get IM Testosterone.  Patient brings own vials from pharmacy.  Partial dose of 0.3 ml was drawn up from previously used vial.  Remaining dose of 0.4 mls was mistakenly drawn up from Covid Bivalent vial in the same syringe.  This was administered to patient.  After administration of medication, RN noticed the error.  Patients last monovalent dose was given 08/08/22.  Dr., lead provider was notified of incident.  Patient was informed of incident and advised of symptoms to report.  Patient did not report any symptoms at this time.  Patients PCP, Dr. was notified of incident.  Will follow up with patient in 48 hours.
dizziness, hot flushing, sweating, blurry vision 5 minutes after vaccination.  Pt did not pass out but did fall to ground.  Pt felt better immediately upon being placed flat on ground (pt was also placed in trendelenberg position).  Pt had not eaten prior to vaccination.  Staff gave pt water & cookies & pt able to recover s incident.
FEELING COLD; CHILLS; This spontaneous report received from a parent concerned a 21 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included seasonal allergies. The patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 12:57 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced feeling cold. On 09-APR-2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills, and feeling cold. This report was non-serious.
Rash over trunk and extremities-macular, papular was slightly pink and rough and fine.
Sudden onset of lower extremity weakness, abnormal gait. 11/12/2009  Neuro consult records and labs/dx studies for 11/9/2009, patient with c/o's lower extremity weakness, numbness of thighs and abnormal gait.  Neuro exam noted decreased DTR's LE's. No DC DX noted.
pain; fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain) and FATIGUE (fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (pain) and FATIGUE (fatigue). At the time of the report, PAIN (pain) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant Medications were reported. No Treatment Information Provided.
Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Error: Wrong Route (SC, IM, etc.)
Client receive Tdap; MCV4; influenza; varicella; HAV. After GARDASIL given client passed out in chair. Mother reports she had not eaten since 12PM. Client recovered within 1/2 hour, Sprite & crackers given. Client left 1/2 hour later.
Face Flush, Chills to the bone and body felt like it was on fire while I was having chills but had no fever.
Initially chilled, then flushed with heat, shaky, dizzy, weak, nausea.  All hit very suddenly. Went to lie down. Had friend drive me home. Fullness in throat with continued symptoms but less severe. Home and to bed. NyQuil. Much better today, still a bit weak at 8:30 AM.
No reported adverse events have occurred to our knowledge, however, the facility was told the patient received a booster 03/06/2022 and was not eligible for a booster dose but gave it anway. I am reporting on behalf of the facility as we are the vaccine provider.
She prescribed Molnupiravir 200mg oral 4 capsules twice daily for 5 days. The symptoms were sore throat and runny nose. I've had the runny nose for a long time but it was worst. I had the sore throat on Friday or Saturday. By Sunday when I saw the nurse, I was more congested and coughed a bit. I never ran a fever and my pulse was high at 99 which is usually high for me, but my oxygen saturation was normal. No GI symptoms. No shortness of breath or chest pain. I didn't feel well, felt disembodied and ears felt clogged up. I felt dizzy and spacy. I had a relapse after the antiviral medication. Thursday 03/30 was my last day of the medication and I felt better after being sick all along. By Friday, I noticed I had gotten gradually better, but I was still having congestion, runny nose, and sneezing and feeling disembodied. My pulse had also gone back down to around 65, which is normal for me. Then I started feeling sick again on 04/01/2023. I took another COVID-19 test on 04/03 and I was positive. I called my doctor's office on Monday and talked to a nurse over the phone. I was instructed to isolate for another 5 days and I'm still masked when out in public. I would consider myself all better by now. I do get tired real easily, and occasionally feel weak and shaky, but I have started exercising again. I started using Fluticasone to help with nasal congestion. The dosage is 50mg per squirt. I've been doing two squirts in each nostril twice a day. Today I started doing one squirt twice a day to taper off. It's been helping a lot. I did talk to my PCP at some point when I got my COVID-19 test.
She has a bump where the needle went in, loos like a mosquito bite, there is a secons about an inch away.; arm is sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (She has a bump where the needle went in, loos like a mosquito bite, there is a secons about an inch away.) and MYALGIA (arm is sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (She has a bump where the needle went in, loos like a mosquito bite, there is a secons about an inch away.) and MYALGIA (arm is sore). At the time of the report, VACCINATION SITE MASS (She has a bump where the needle went in, loos like a mosquito bite, there is a secons about an inch away.) and MYALGIA (arm is sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not mentioned. Treatment medications were not provided
27Dec2020 - patient developed some swelling (went about 1 inch out from injection site) and discomfort at the injection site - had taken Advil and was using a cool compress.  29Dec2020 - patient had to leave work early since she was not feeling well - very fatigued and a little dizzy (able to eat/drink) - denied any COVID illness s/s (no cough, fever, loss of taste/smell, etc).  She ended up going to the local ED - since she was still very fatigued and was feeling like she was going to pass out - blood work and U/S done - this is where she found out she had been pregnant but had lost the pregnancy (no heart beat).  Per her report - all other blood work was unremarkable.  No other medications given to her during this visit and was just told that she would be 'passing the products of conception within this next week'.
Patient received a monovalent instead of the bivalent for a booster. Monovalent does was also expired on 11/4/2022 which is outside of the 10 week refrigeration date. Dose was given on 11/11/2022
parent came to clinic on 11SEP97 3 days p/vax & stated pt arm is red & swollen;instructed to see MD; pt brought in deferment from a MD who never saw the arm;sx lasted about 7 days per parent;
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
never woke up after arrival; Suffered with vascular dementia; Death cause: Covid/Tested positive to Covid 31Jan, tested due to increased lethargy; This is a spontaneous report from a contactable consumer. An 85-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 22Jan2021 at single dose for COVID-19 immunization. The patient received the vaccine at nursing home/senior living facility. Medical history included dementia, hypertension, past strokes. The patient was exposed to asymptotic staff member on or prior to 25Jan2021. The patient had no known allergy. No COVID prior vaccination. Concomitant medication included lisinopril. No other vaccine was received in four weeks. The patient was tested positive to COVID on 31Jan2021, tested due to increased lethargy started from 26Jan2021. The patient suffered with vascular dementia. She was ambulatory up to 31Jan2021. The patient was sent to hospice that evening on 31Jan2021 to quarantine, never woke up after arrival. Palliative Care started 02Feb2021, the patient expired 12Feb2021. Cause of death was COVID. The patient did not receive treatment for events. The autopsy was not performed. The outcome of events "never woke up, vascular dementia" was unknown.   Information on Lot /Batch Number has been requested.; Reported Cause(s) of Death: Death cause: Covid
Had convuls approx 4-5min p/leaving Hlth Dept; Tx Pred & DPH & O2 overnight @ Hosp;
Pt presented swelling, cold, pink-purple looking arm which is also the vaccinated arm about a week after the vaccination. Pt felt pain and strength less. She could not lift up her arm. She was recommended to go to emergency room immediately.
Initial information received on 14-Feb-2019 regarding an unsolicited valid non-serious case received from a physician. This case involves a 45 years old male patient who fall, while he received vaccine FLUZONE QUADRIVALENT. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route in unknown administration site. The patient fall (Unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. List of documents held by sender: none.